About: Isabelle Sermet-Gaudelus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Isabelle Sermet-Gaudelus Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle
preferred label	Sermet-Gaudelus, Isabelle
name	Isabelle Sermet-Gaudelus
isni:identifierValid	0000000402423760
Given name	Isabelle
familyName	Sermet-Gaudelus
note	Directrice de thèse à l'Université Pierre et Marie Curie - Paris 6 en 2012. Professeur de pédiatrie à Université Paris Cité (lnstitut Necker. Enfants Malades, INSERM U1151) en 2024
gender	female
ORCID iD	0000-0001-5537-9482
Scopus ID	55885104100
is sameAs of	Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle
is Thesis advisor of	Utilisation des bactériophages comme thérapie lors d'une infection à Pseudomonas aeruginosa dans le cadre de la mucoviscidose, efficacité et innocuité http://www.sudoc.fr/168357410/id http://www.sudoc.fr/078795206/id http://www.sudoc.fr/268848971/id http://www.sudoc.fr/24802650X/id http://www.sudoc.fr/270693785/id http://www.sudoc.fr/235814024/id http://www.sudoc.fr/241077087/id http://www.sudoc.fr/272335649/id http://www.sudoc.fr/259814571/id
is Praeses of	http://www.sudoc.fr/194040887/id http://www.sudoc.fr/242526691/id http://www.sudoc.fr/226864340/id
is Author of	Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients Recommendations for the classification of diseases as CFTR-related disorders Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9 Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways Characterization of SLC26A9 in Patients with CF-Like Lung Disease Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators The hsa-miR-125a/hsa-let-7e/hsa-miR-99b cluster is potentially implicated in Cystic Fibrosis pathogenesis Measurement of Immunoglobulin G against Mycobacterial Antigen A60 in Patients with Cystic Fibrosis and Lung Infection Due to Mycobacterium abscessus French law: what about a reasoned reimbursement of serum vitamin D assays? Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forward Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity Chronic Staphylococcus aureus Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients. Guidelines for the management of children at risk of secondary bone fragility: Expert opinion of a French working group Mutations in GAS8 , a Gene Encoding a Nexin-Dynein Regulatory Complex Subunit, Cause Primary Ciliary Dyskinesia with Axonemal Disorganization Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis? Exon identity influences splicing induced by exonic variants and in silico prediction efficacy An unexpected effect of TNF-α on F508del-CFTR maturation and function Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response? Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients Penetrance is a critical parameter for assessing the disease liability of CFTR variants Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy? Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020 The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening Déterminants du refus de la vaccination contre le virus pandémique A/H1N1 dans une population à haut risque: Une approche qualitative CFTR: New insights into structure and function and implications for modulation by small molecules Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Cis variants identified in F508del complex alleles modulate CFTR channel rescue by small molecules Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis [Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement] Increased expression of ATP12A proton pump in cystic fibrosis airways Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice. Genetic testing to provide targeted treatment for cystic fibrosis patients. Moving the Dial on Airway Inflammation in Response to Trikafta® in Adolescents with Cystic Fibrosis Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function http://hub.abes.fr/edp/periodical/medsci/2024/volume_40/issue_3/msc230299/w Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites https://archive-ouverte.unige.ch/unige:136664#id Proteomic profiling of sweat in patients with cystic fibrosis provides new insights into epidermal homoeostasis Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice Impact of COVID-19 on people with cystic fibrosis Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test Immunological and virological profile of children with chilblain‐like lesions and SARS‐CoV‐2 Genomic analysis of Staphylococcus aureus sequential isolates from lungs of patients with cystic fibrosis
is primary topic of	http://www.idref.fr/16835781X
is Opponent of	http://www.sudoc.fr/085053309/id http://www.sudoc.fr/267651686/id http://www.sudoc.fr/246792744/id Mise au point d'une méthode de thérapie génique utilisant le PEI et analyse du phénotype osseux dans un modèle murin de mucoviscidose

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software